K. Taylor

CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age‐ and sex‐matched population data

B. Hock, J. McKenzie, L. McArthur, 2010, Internal medicine journal.

Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies

M. Drayson, H. Kantarjian, F. Giles, 2006, Cancer.

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.

A. Steinkasserer, B. Hock, J. McKenzie, 2004, Leukemia research.

Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability

A. Kettle, M. Hampton, B. Hock, 2012, Immunology.

Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.

A. Steinkasserer, J. O'donnell, B. Hock, 2006, Tissue antigens.

Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.

B. Hock, J. McKenzie, M. Currie, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Circulating levels and clinical significance of soluble CD86 in myeloma patients

M. Drayson, J. McKenzie, W. Patton, 2006, British journal of haematology.

Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.

B. Hock, J. McKenzie, M. Currie, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.